Provided by Tiger Trade Technology Pte. Ltd.

Molecular Partners AG

4.40
+0.16994.02%
Post-market: 4.400.00000.00%17:18 EDT
Volume:504
Turnover:2.21K
Market Cap:164.55M
PE:-2.27
High:4.40
Open:4.38
Low:4.38
Close:4.23
52wk High:5.36
52wk Low:3.53
Shares:37.40M
Float Shares:19.92M
Volume Ratio:0.35
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9371
EPS(LYR):-2.0808
ROE:-59.01%
ROA:-28.82%
PB:1.93
PE(LYR):-2.11

Loading ...

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

GlobeNewswire
·
May 01

Molecular Partners announces presentation of preclinical data at AACR

TIPRANKS
·
Apr 20

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

GlobeNewswire
·
Apr 20

Press Release: Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting

Dow Jones
·
Apr 15

Press Release: Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors

Dow Jones
·
Mar 23

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Mar 19

Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes

GlobeNewswire
·
Mar 19

Molecular Partners to Hold Three Poster Presentations at AACR 2026

GlobeNewswire
·
Mar 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:54 PM

Reuters
·
Mar 17

Molecular Partners (MOLN) Gets a Buy from Clear Street

TIPRANKS
·
Mar 13

Molecular Partners Reports Highlights and Financial Results for Full Year 2025

GlobeNewswire
·
Mar 13

Molecular Partners AG expected to post a loss of 29 rappen a share - Earnings Preview

Reuters
·
Mar 10

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results

GlobeNewswire
·
Feb 26

Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics

GlobeNewswire
·
Feb 26